(1)
Babczyńska, M.; Buliszak, A.; Marcjasz, P.; Bioły, A.; Borończyk, A.; Zając, P. Comparative Effectiveness of Risankizumab Vs Other Biologics in Crohn’s Disease: Long-Term and Quality-of-Life Outcomes After Inadequate Response to Prior Therapy. Qual Sport 2025, 41, 59986.